litlas
ログインアカウント作成

Rosemarie Mick

1987–2024 年に発表

101
論文数
21,131
被引用数
84
h 指数
101
i10 指数

被引用数

Rosemarie Mick の年別被引用数1988 年: 被引用 5 件1989 年: 被引用 7 件1990 年: 被引用 9 件1991 年: 被引用 10 件1992 年: 被引用 11 件1993 年: 被引用 12 件1994 年: 被引用 21 件1995 年: 被引用 34 件1996 年: 被引用 26 件1997 年: 被引用 37 件1998 年: 被引用 53 件1999 年: 被引用 59 件2000 年: 被引用 68 件2001 年: 被引用 83 件2002 年: 被引用 87 件2003 年: 被引用 104 件2004 年: 被引用 115 件2005 年: 被引用 127 件2006 年: 被引用 117 件2007 年: 被引用 126 件2008 年: 被引用 121 件2009 年: 被引用 142 件2010 年: 被引用 108 件2011 年: 被引用 114 件2012 年: 被引用 111 件2013 年: 被引用 145 件2014 年: 被引用 122 件2015 年: 被引用 167 件2016 年: 被引用 230 件2017 年: 被引用 223 件2018 年: 被引用 266 件2019 年: 被引用 695 件2020 年: 被引用 927 件2021 年: 被引用 875 件2022 年: 被引用 685 件2023 年: 被引用 537 件2024 年: 被引用 771 件2025 年: 被引用 313 件2026 年: 被引用 14 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,494 件、この内訳の 34%中国: 引用元論文 1,218 件、この内訳の 11.8%ドイツ: 引用元論文 555 件、この内訳の 5.4%イギリス: 引用元論文 523 件、この内訳の 5.1%イタリア: 引用元論文 419 件、この内訳の 4.1%フランス: 引用元論文 388 件、この内訳の 3.8%オランダ: 引用元論文 336 件、この内訳の 3.3%カナダ: 引用元論文 316 件、この内訳の 3.1%日本: 引用元論文 304 件、この内訳の 2.9%オーストラリア: 引用元論文 283 件、この内訳の 2.7%スイス: 引用元論文 254 件、この内訳の 2.5%スペイン: 引用元論文 212 件、この内訳の 2.1%
0%34%その他 19.2%

機関

分野

  • Medicine61.6%
  • Biochemistry, Genetics and Molecular Biology17.8%
  • Immunology and Microbiology15.3%
  • Engineering2.5%
  • Materials Science0.5%
  • Mathematics0.4%
  • その他1.9%

トピック

  • Cancer Immunotherapy and Biomarkers12.4%
  • Immunotherapy and Immune Responses7.9%
  • CAR-T cell therapy research4.8%
  • Immune Cell Function and Interaction4.3%
  • Pancreatic and Hepatic Oncology Research2.9%
  • Immune cells in cancer2.8%
  • その他64.9%

共著者

全論文

検索で開く
  1. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

    著者: Christina Twyman-Saint Victor, Andrew J. Rech, Amit Maity, Ramesh Rengan, Kristen E. Pauken, Erietta Stelekati, Joseph L. Benci, Bihui Xu, Hannah Dada, Pamela M. Odorizzi, Ramin S. Herati, Kathleen D. Mansfield, Dana Patsch, Ravi K. Amaravadi, Lynn M. Schuchter, Hemant Ishwaran, Rosemarie Mick, Daniel A. Pryma, Xiaowei Xu, Michael D. Feldman, Tara C. Gangadhar, Stephen M. Hahn, E. John Wherry, Robert H. Vonderheide, Andy J. Minn - Nature 2015 被引用: 2,431

  2. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response

    著者: Alexander C. Huang, Michael A. Postow, Robert J. Orlowski, Rosemarie Mick, Bertram Bengsch, Sasikanth Manne, Wei Xu, Shannon Harmon, Josephine R. Giles, Brandon M. Wenz, Matthew Adamow, Deborah Kuk, Katherine S. Panageas, Cristina Carrera, Phillip Wong, Felix Quagliarello, Bradley Wubbenhorst, Kurt D’Andrea, Kristen E. Pauken, Ramin S. Herati, Ryan P. Staupe, Jason M. Schenkel, Suzanne McGettigan, Shawn Kothari, Sangeeth M. George, Robert H. Vonderheide, Ravi K. Amaravadi, Giorgos C. Karakousis, Lynn M. Schuchter, Xiaowei Xu, Katherine L. Nathanson, Jedd D. Wolchok, Tara C. Gangadhar, E. John Wherry - Nature 2017 被引用: 1,690

  3. Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

    著者: Lacey Padrón, Deena M. Maurer, Mark H. O’Hara, Eileen M. O’Reilly, Robert A. Wolff, Zev A. Wainberg, Andrew H. Ko, George A. Fisher, Osama E. Rahma, Jaclyn P. Lyman, Christopher R. Cabanski, Jia Xin Yu, Shannon M. Pfeiffer, Marko Spasić, Jingying Xu, Pier Federico Gherardini, Joyson Karakunnel, Rosemarie Mick, Cécile Alanio, Katelyn T. Byrne, Travis J. Hollmann, Jonni S. Moore, Derek D. Jones, Marco Tognetti, Richard Chen, Xiaodong Yang, Lisa Salvador, E. John Wherry, Ute Dugan, Jill O’Donnell-Tormey, Lisa H. Butterfield, Vanessa M. Hubbard-Lucey, Ramy Ibrahim, Justin Fairchild, Samantha Bucktrout, Theresa LaVallee, Robert H. Vonderheide - Nature Medicine 2022 被引用: 350

  4. A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma

    著者: Alexander C. Huang, Robert Orlowski, Xiaowei Xu, Rosemarie Mick, Sangeeth M. George, Patrick Yan, Sasikanth Manne, Adam Kraya, Bradley Wubbenhorst, Liza M. Dorfman, Kurt D’Andrea, Brandon M. Wenz, Shujing Liu, Lakshmi Chilukuri, Andrew Kozlov, Mary Carberry, Lydia Giles, Melanie Wain Kier, Felix Quagliarello, Suzanne McGettigan, Kristin Kreider, Lakshmanan Annamalai, Qing Zhao, Robin Mogg, Wei Xu, Wendy M. Blumenschein, Jennifer H. Yearley, Gerald P. Linette, Ravi K. Amaravadi, Lynn M. Schuchter, Ramin S. Herati, Bertram Bengsch, Katherine L. Nathanson, Michael D. Farwell, Giorgos C. Karakousis, E. John Wherry, Tara C. Mitchell - Nature Medicine 2019 被引用: 702

  5. CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study

    著者: Mark H. O’Hara, Eileen M. O’Reilly, Gauri R. Varadhachary, Robert A. Wolff, Zev A. Wainberg, Andrew H. Ko, George A. Fisher, Osama E. Rahma, Jaclyn P. Lyman, Christopher R. Cabanski, Rosemarie Mick, Pier Federico Gherardini, Lacey J. Kitch, Jingying Xu, Theresa Samuel, Joyson Karakunnel, Justin Fairchild, Samantha Bucktrout, Theresa LaVallee, Cheryl Selinsky, Jacob E. Till, Erica L. Carpenter, Cécile Alanio, Katelyn T. Byrne, Richard O Chen, Ovid Trifan, Ute Dugan, Christine E. Horak, Vanessa M. Hubbard-Lucey, E. John Wherry, Ramy Ibrahim, Robert H. Vonderheide - The Lancet Oncology 2020 被引用: 301

  6. Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer

    著者: János L. Tanyi, Sara Bobisse, Eran Ophir, Sandra Tuyaerts, Annalisa Roberti, Raphaël Genolet, Petra Baumgärtner, Brian J. Stevenson, Christian Iseli, Denarda Dangaj Laniti, Brian J. Czerniecki, Aikaterini Semilietof, Julien Racle, Alexandra Michel, Ioannis Xénarios, Cheryl Chiang, Dimitri Monos, Drew A. Torigian, Harvey Nisenbaum, Olivier Michielin, Carl H. June, Bruce L. Levine, Daniel J. Powell, David Gfeller, Rosemarie Mick, Urania Dafni, Vincent Zoete, Alexandre Harari, George Coukos, Lana E. Kandalaft - Science Translational Medicine 2018 被引用: 441

  7. Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to Invasion

    著者: Carolyn E. Clark, Sunil R. Hingorani, Rosemarie Mick, Chelsea Combs, David A. Tuveson, Robert H. Vonderheide - Cancer Research 2007 被引用: 993

  8. Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer

    著者: Katelyn T. Byrne, Courtney B. Betts, Rosemarie Mick, Shamilene Sivagnanam, David L. Bajor, Daniel A. Laheru, E. Gabriela Chiorean, Mark H. O’Hara, Shannon M. Liudahl, Craig Newcomb, Cécile Alanio, Ana Paula Ferreira, Byung Park, Takuya Ohtani, Austin P. Huffman, Sara A. Väyrynen, Andressa Dias Costa, Judith C. Kaiser, Andreanne M. Lacroix, Colleen Redlinger, Martin Stern, Jonathan A. Nowak, E. John Wherry, Martin A. Cheever, Brian M. Wolpin, Emma E. Furth, Elizabeth M. Jaffee, Lisa M. Coussens, Robert H. Vonderheide - Clinical Cancer Research 2021 被引用: 180

  9. Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2

    著者: Kim A. Reiss, Rosemarie Mick, Mark H. O’Hara, Ursina Teitelbaum, Thomas B. Karasic, Charles Schneider, Stacy Cowden, Traci Southwell, Janae Romeo, Natallia Izgur, Zain M. Hannan, Rashmi Tondon, Katherine L. Nathanson, Robert H. Vonderheide, Max M. Wattenberg, Gregory L. Beatty, Susan M. Domchek - Journal of Clinical Oncology 2021 被引用: 239

  10. Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial

    著者: Kim A. Reiss, Rosemarie Mick, Ursina Teitelbaum, Mark H. O’Hara, Charles Schneider, Ryan Massa, Thomas B. Karasic, Rashmi Tondon, Chioma Onyiah, Mary Kate Gosselin, Alyssa Donze, Susan M. Domchek, Robert H. Vonderheide - The Lancet Oncology 2022 被引用: 139

  11. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis

    著者: Penelope C. Georges, Jia–Ji Hui, Zoltán Gombos, Margaret E. McCormick, Andrew Y. Wang, Masayuki Uemura, Rosemarie Mick, Paul A. Janmey, Emma E. Furth, Rebecca G. Wells - American Journal of Physiology-Gastrointestinal and Liver Physiology 2007 被引用: 577

  12. CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients

    著者: Andrew J. Rech, Rosemarie Mick, Sunil Martin, Adri Recio, Nicole A. Aqui, Daniel J. Powell, Theresa A. Colligon, Jennifer A. Trosko, Leah I. Leinbach, Charles H. Pletcher, Carol Tweed, Angela DeMichele, Kevin R. Fox, Susan M. Domchek, James L. Riley, Robert H. Vonderheide - Science Translational Medicine 2012 被引用: 328

  13. Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer

    著者: Joshua Bauml, Rosemarie Mick, Christine Ciunci, Charu Aggarwal, Christiana Davis, Tracey L. Evans, Charuhas Deshpande, Linda Miller, Pooja Patel, Evan Alley, Christina Knepley, Faith Mutale, Roger B. Cohen, Corey J. Langer - JAMA Oncology 2019 被引用: 320

  14. A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

    著者: Cheryl Lai-Lai Chiang, Lana E. Kandalaft, János L. Tanyi, Andrea R. Hagemann, Gregory T. Motz, Nikolaos Svoronos, Kathleen T. Montone, Gina Mantia-Smaldone, Lori Smith, Harvey Nisenbaum, Bruce L. Levine, Michael Kalos, Brian J. Czerniecki, Drew A. Torigian, Daniel J. Powell, Rosemarie Mick, George Coukos - Clinical Cancer Research 2013 被引用: 216

  15. Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors

    著者: Robert H. Vonderheide, Jennifer M. Burg, Rosemarie Mick, Jennifer A. Trosko, Dongguang Li, M. Naveed Shaik, Anthony W. Tolcher, Omid Hamid - OncoImmunology 2013 被引用: 203

  16. Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design Trial

    著者: Lea Lowenfeld, Rosemarie Mick, Jashodeep Datta, Shuwen Xu, Elizabeth Fitzpatrick, Carla S. Fisher, Kevin R. Fox, Angela DeMichele, Paul J. Zhang, Susan P. Weinstein, Robert E. Roses, Brian J. Czerniecki - Clinical Cancer Research 2016 被引用: 151

  17. BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600 -mutant Melanoma

    著者: Janice M. Mehnert, Tara C. Mitchell, Alexander C. Huang, Tomas S. Aleman, Benjamin J. Kim, Lynn M. Schuchter, Gerald P. Linette, Giorgos C. Karakousis, Sheryl Mitnick, Lydia Giles, Mary Carberry, Noelle Frey, Andrew Kossenkov, Roman Groisberg, Leonel F. Hernandez-Aya, George Ansstas, Ann W. Silk, Sunandana Chandra, Jeffrey A. Sosman, Phyllis A. Gimotty, Rosemarie Mick, Ravi K. Amaravadi - Clinical Cancer Research 2022 被引用: 61

  18. HER‐2 pulsed dendritic cell vaccine can eliminate HER‐2 expression and impact ductal carcinoma in situ

    著者: Anupama Sharma, Ursula Koldovsky, Shuwen Xu, Rosemarie Mick, Robert E. Roses, Elizabeth Fitzpatrick, Susan P. Weinstein, Harvey Nisenbaum, Bruce L. Levine, Kevin R. Fox, Paul Zhang, Gary K. Koski, Brian J. Czerniecki - Cancer 2012 被引用: 165

  19. Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma

    著者: David L. Bajor, Rosemarie Mick, Matthew J. Riese, Alex C. Huang, Brendan Sullivan, Lee P. Richman, Drew A. Torigian, Sangeeth M. George, Erietta Stelekati, Fang Chen, J. Joseph Melenhorst, Simon F. Lacey, Xiaowei Xu, E. John Wherry, Tara C. Gangadhar, Ravi K. Amaravadi, Lynn M. Schuchter, Robert H. Vonderheide - OncoImmunology 2018 被引用: 120

  20. Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer

    著者: János L. Tanyi, Cheryl Lai-Lai Chiang, Johanna Chiffelle, Anne‐Christine Thierry, Petra Baumgartener, Florian Huber, Christine Goepfert, David Tarussio, Stephanie Tissot, Drew A. Torigian, Harvey Nisenbaum, Brian J. Stevenson, Hajer Fritah Guiren, Ritaparna Ahmed, Anne-Laure Huguenin-Bergenat, Emese Zsíros, Michal Bassani‐Sternberg, Rosemarie Mick, Daniel J. Powell, George Coukos, Alexandre Harari, Lana E. Kandalaft - npj Vaccines 2021 被引用: 47

  21. Targeting HER-2/ neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion

    著者: Brian J. Czerniecki, Gary K. Koski, Ursula Koldovsky, Shuwen Xu, Peter A. Cohen, Rosemarie Mick, Harvey Nisenbaum, Terry Pasha, Min Xu, Kevin R. Fox, Susan P. Weinstein, Susan G. Orel, Robert H. Vonderheide, George Coukos, Angela DeMichele, Louis Araujo, Francis R. Spitz, Mark Rosen, Bruce L. Levine, Carl H. June, Paul J. Zhang - Cancer Research 2007 被引用: 266

  22. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non–Small Cell Lung Cancer

    著者: Hann‐Hsiang Chao, Abigail T. Berman, Charles B. Simone, Christine Ciunci, Peter Gabriel, Haibo Lin, Stefan Both, Corey J. Langer, Kristi Lelionis, Ramesh Rengan, Stephen M. Hahn, Kiran Prabhu, Marcio Fagundes, William F. Hartsell, Rosemarie Mick, John P. Plastaras - Journal of Thoracic Oncology 2016 被引用: 123

  23. A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours

    著者: Amit Maity, Rosemarie Mick, Alexander C. Huang, Sangeeth M. George, Michael D. Farwell, John N. Lukens, Abigail T. Berman, Tara C. Mitchell, J. Bauml, Lynn M. Schuchter, Mark H. O’Hara, Lilie L. Lin, Angela DeMichele, John P. Christodouleas, Naomi B. Haas, Dana Patsch, Stephen M. Hahn, Andy J. Minn, E. John Wherry, Robert H. Vonderheide - British Journal of Cancer 2018 被引用: 103

  24. Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea.

    著者: E Gupta, Timothy M. Lestingi, Rosemarie Mick, Jesús Ramı́rez, Everett E. Vokes, MJ Ratain - 1994 被引用: 506